References
- Madisch, A., Holtmann, G., Plein, K., & Hotz, J. (2004). Treatment of irritable bowel syndrome with herbal preparations: Results of a double-blind, randomized, placebo-controlled, multi-centre trial. Alimentary Pharmacology & Therapeutics, 19(8), 957-965. https://doi.org/10.1111/j.1365-2036.2004.01859.x
- Aguilar, A., Benslaiman, B., & Serra, J. (2019). Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double-blind, placebo-controlled clinical trial. Neurogastroenterology & Motility, 31(6), e14765. https://doi.org/10.1111/nmo.14765
- Müller, M. H., Liu, C.-Y., Glatzle, J., Weiser, D., Kelber, O., Enck, P., Grundy, D., & Kreis, M. E. (2006). STW 5 (Iberogast) reduces afferent sensitivity in the rat small intestine. Phytomedicine, 13(9-10), 633639. https://doi.org/10.1016/j.phymed.2006.03.014
- Merat, S., Khalili, S., Mostajabi, P., Ghorbani, A., Ansari, R., & Malekzadeh, R. (2009). The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome. Digestive Diseases and Sciences, 54(8), 1737-1743. https://doi.org/10.1007/s10620-009-0854-9
- Cappello, G., Spezzaferro, M., Grossi, L., Manzoli, L., & Marzio, L. (2007). Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: A prospective double-blind placebo-controlled randomized trial. Digestive and Liver Disease, 39(12), 1061-1065. https://doi.org/10.1016/j.dld.2007.02.006
- Di Ciaula, A., Portincasa, P., Maes, N., & Albert, A. (2018). Efficacy of bio-optimized extracts of turmeric and essential fennel oil on the quality of life in patients with irritable bowel syndrome. Annals of Gastroenterology, 31(3), 318-323. https://doi.org/10.20524/aog.2018.0304
- Portincasa, P., Bonfrate, L., Scribano, M. L. L., Kohn, A., Caporaso, N., Festi, D., Campanale, M. C., Di Rienzo, T., Guarino, M., Taddia, M., Fogli, M. V., Grimaldi, M., & Gasbarrini, A. (2014). Curcumin and fennel essential oil improve symptoms and quality of life in patients with irritable bowel syndrome. Journal of Gastrointestinal and Liver Diseases, 23(4), 441-448. https://doi.org/10.15403/jgld.2014.1121.252.ccm
- Zhang, M., Zhao, R., Wang, D., Wang, L., Zhang, Q., Wei, S., Lu, F., Peng, W., & Wu, C. (2019). Ginger (Zingiber officinale Rosc.) and its bioactive components are potential resources for health-beneficial agents. Phytotherapy Research, 33(3), 423-440. https://doi.org/10.1002/ptr.6858
- van Tilburg, M. A. L., Palsson, O. S., Ringel, Y., & Whitehead, W. E. (2014). Is ginger effective for the treatment of irritable bowel syndrome? A double-blind randomized controlled pilot trial. Complementary Therapies in Medicine, 22(5), 714-720. https://doi.org/10.1016/j.ctim.2013.12.015